<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04580043</url>
  </required_header>
  <id_info>
    <org_study_id>MOD19090219-002</org_study_id>
    <secondary_id>R01MH124707</secondary_id>
    <nct_id>NCT04580043</nct_id>
  </id_info>
  <brief_title>Theta Burst Stimulation Plus Habit Override Training for Compulsive Behaviors</brief_title>
  <official_title>Experimental Manipulation of OFC Function and Behavioral Context: Towards an Integrative Translational Model of Compulsive Behaviors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rebecca Price</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project seeks to identify causal neural mechanisms underlying unwanted, repetitive&#xD;
      behaviors (compulsions). Using non-invasive brain stimulation coupled with practice in a&#xD;
      computer task, we will modulate activity in a target brain region and measure effects on&#xD;
      compulsive behaviors and related measures. This work could ultimately lead to the ability to&#xD;
      treat compulsions more effectively by targeting the regions of the brain that can help or&#xD;
      hinder attempts to overcome compulsions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 28, 2020</start_date>
  <completion_date type="Anticipated">January 2, 2027</completion_date>
  <primary_completion_date type="Anticipated">January 2, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain activation in target region</measure>
    <time_frame>10-60min post-intervention</time_frame>
    <description>Mean Cerebral Blood Flow (CBF) in orbitofrontal cortex collected via functional Magnetic Resonance Imaging (fMRI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effort to resist compulsive behaviors in response to laboratory triggers</measure>
    <time_frame>60min post-intervention</time_frame>
    <description>Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: self-reported effort needed to resist (0-100 scale)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of compulsive behaviors in response to laboratory triggers</measure>
    <time_frame>60min post-intervention</time_frame>
    <description>Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: duration of compulsive behavior performance (% of total time allotted)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intensity of urges to perform compulsive behaviors in response to laboratory triggers</measure>
    <time_frame>60min post-intervention</time_frame>
    <description>Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: self-reported urge intensity (0-100 scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Goal-directed cognition</measure>
    <time_frame>90min-1 week</time_frame>
    <description>Neuropsychological test of flexible goal-directed cognition (two-step task): switch score (higher score=better performance)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Yale-Brown Obsessive Compulsive Scale (Y-BOCS)</measure>
    <time_frame>1 week</time_frame>
    <description>Clinician-administered measurement of obsessions and compulsions (range: 0-40; higher score=worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WHO Disability Assessment Scale 2.0</measure>
    <time_frame>1 week</time_frame>
    <description>Self-report measure of general functioning and disability (0-100; higher score=worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obsessive Compulsive Inventory-Revised (OCI-R)</measure>
    <time_frame>1 week</time_frame>
    <description>Self-report measure of obsessions and compulsions (0-72; higher score=worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effort to resist compulsive behaviors in response to laboratory triggers</measure>
    <time_frame>1 week</time_frame>
    <description>Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: self-reported effort needed to resist (0-100 scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of compulsive behaviors in response to laboratory triggers</measure>
    <time_frame>1 week</time_frame>
    <description>Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: duration of compulsive behavior performance (% of total time allotted)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity of urges to perform compulsive behaviors in response to laboratory triggers</measure>
    <time_frame>1 week</time_frame>
    <description>Custom-made laboratory assessment of ability to override compulsive behaviors in response to idiographic triggers: self-reported urge intensity (0-100 scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain activation in target region</measure>
    <time_frame>1 week</time_frame>
    <description>Mean Cerebral Blood Flow (CBF) in orbitofrontal cortex collected via functional Magnetic Resonance Imaging (fMRI)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Compulsive Behavior</condition>
  <condition>Obsessive-Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>cTBS + Habit Override Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcranial Magnetic Stimulation delivered in a continuous Theta Burst Stimulation (cTBS) pattern, paired with Habit Override Training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham TBS + Habit Override Training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sham Transcranial Magnetic Stimulation, paired with Habit Override Training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cTBS + Sham Training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transcranial Magnetic Stimulation delivered in a continuous Theta Burst Stimulation (cTBS) pattern, paired with Sham Training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham TBS + Sham Training</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham Transcranial Magnetic Stimulation, paired with Sham Training.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Habit Override Practice</intervention_name>
    <description>Computerized &quot;brain training&quot; to provide practice in overriding avoidance habits.</description>
    <arm_group_label>Sham TBS + Habit Override Training</arm_group_label>
    <arm_group_label>cTBS + Habit Override Training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation</intervention_name>
    <description>Non-invasive method for temporary, focal stimulation of brain areas. Delivered in a continuous Theta Burst Stimulation (TBS) pattern.</description>
    <arm_group_label>cTBS + Habit Override Training</arm_group_label>
    <arm_group_label>cTBS + Sham Training</arm_group_label>
    <other_name>cTBS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sham Training</intervention_name>
    <description>Computer-based task practice in a non-active/inert task.</description>
    <arm_group_label>Sham TBS + Sham Training</arm_group_label>
    <arm_group_label>cTBS + Sham Training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Transcranial Magnetic Stimulation</intervention_name>
    <description>Sham stimulation of non-brain areas. Delivered in a continuous Theta Burst Stimulation (TBS) pattern.</description>
    <arm_group_label>Sham TBS + Habit Override Training</arm_group_label>
    <arm_group_label>Sham TBS + Sham Training</arm_group_label>
    <other_name>Sham cTBS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Participants will:&#xD;
&#xD;
          1. Be between the ages of 18 and 60 years&#xD;
&#xD;
          2. Endorse problematic compulsive behaviors, per self-report and clinician-administered&#xD;
             measures.&#xD;
&#xD;
          3. Agree to video taping of structured clinical interview&#xD;
&#xD;
          4. Report that they will reside in the Pittsburgh area for at least 5 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Failure to meet standard MRI inclusion criteria: those who endorse claustrophobia,&#xD;
             those who have cardiac pacemakers, neural pacemakers, surgical clips in the brain or&#xD;
             blood vessels, surgically implanted metal plates, screws or pins, cochlear implants,&#xD;
             implanted uterine devices, metal braces, or other metal objects in their body,&#xD;
             especially in the eye. Dental fillings do not present a problem. Plastic or removable&#xD;
             dental appliances do not require exclusion. History of significant injury or surgery&#xD;
             to the brain or spinal cord that would impair interpretation of results. Pregnancy,&#xD;
             determined by pregnancy tests on females.&#xD;
&#xD;
          2. Medical contraindications for Transcranial Magnetic Stimulation (TMS):&#xD;
&#xD;
               1. Presence of a neurologic disorder or medication therapy known to alter seizure&#xD;
                  threshold (e.g., stroke, aneurysm, brain surgery, structural brain lesion, brain&#xD;
                  injury, frequent/severe headaches)&#xD;
&#xD;
               2. Recurrent seizures or epilepsy in participant or family history of hereditary&#xD;
                  epilepsy&#xD;
&#xD;
               3. Pregnancy&#xD;
&#xD;
               4. Metallic implants in body or other devices that may be affected by magnetic field&#xD;
&#xD;
               5. Significant heart disease or cerebrovascular disease&#xD;
&#xD;
               6. Medications with seizure threshold lowering potential, e.g., clomipramine,&#xD;
                  Monoamine Oxidase inhibitors (MAOi's), imipramine, clozapine&#xD;
&#xD;
          3. Acute suicidality or other psychiatric crises requiring treatment escalation&#xD;
&#xD;
          4. Changes made to treatment regimen within 4 weeks of baseline assessment&#xD;
&#xD;
          5. Reading level &lt;6th grade&#xD;
&#xD;
          6. Presence of bipolar, psychotic, autism spectrum, or substance use disorder (i.e.&#xD;
             current use of mood altering drugs such as cocaine, cannabis or marijuana, opiates,&#xD;
             amphetamines, and barbiturates)&#xD;
&#xD;
          7. Presence of movement disorder or tics affecting manual responses&#xD;
&#xD;
          8. Inability to read text from 2 feet away (corrective lenses allowed)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca B Price, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rebecca Price, PhD</last_name>
    <phone>4126486445</phone>
    <email>canlab@pitt.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Western Psychiatric Institute and Clinic</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Price, PhD</last_name>
      <phone>412-648-6445</phone>
      <email>canlab@pitt.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>October 1, 2020</study_first_submitted>
  <study_first_submitted_qc>October 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>January 6, 2021</last_update_submitted>
  <last_update_submitted_qc>January 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Rebecca Price</investigator_full_name>
    <investigator_title>Associate Professor of Psychiatry</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
    <mesh_term>Compulsive Behavior</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

